Lactate Is a Metabolic Mediator That Shapes Immune Cell Fate and Function
- PMID: 34733170
- PMCID: PMC8558259
- DOI: 10.3389/fphys.2021.688485
Lactate Is a Metabolic Mediator That Shapes Immune Cell Fate and Function
Abstract
Lactate and the associated H+ ions are still introduced in many biochemistry and general biology textbooks and courses as a metabolic by-product within fast or oxygen-independent glycolysis. However, the role of lactate as a fuel source has been well-appreciated in the field of physiology, and the role of lactate as a metabolic feedback regulator and distinct signaling molecule is beginning to gain traction in the field of immunology. We now know that while lactate and the associated H+ ions are generally immunosuppressive negative regulators, there are cell, receptor, mediator, and microenvironment-specific effects that augment T helper (Th)17, macrophage (M)2, tumor-associated macrophage, and neutrophil functions. Moreover, we are beginning to uncover how lactate and H+ utilize different transporters and signaling cascades in various immune cell types. These immunomodulatory effects may have a substantial impact in cancer, sepsis, autoimmunity, wound healing, and other immunomodulatory conditions with elevated lactate levels. In this article, we summarize the known effects of lactate and H+ on immune cells to hypothesize potential explanations for the divergent inflammatory vs. anti-inflammatory effects.
Keywords: M2; Th17; immune; immunometabolism; immunosuppression; inflammation; lactate; lactic acid.
Copyright © 2021 Caslin, Abebayehu, Pinette and Ryan.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Lactate and Immunosuppression in Sepsis.Shock. 2018 Feb;49(2):120-125. doi: 10.1097/SHK.0000000000000958. Shock. 2018. PMID: 28767543 Free PMC article. Review.
-
The oncogenic and clinical implications of lactate induced immunosuppression in the tumour microenvironment.Cancer Lett. 2021 Mar 1;500:75-86. doi: 10.1016/j.canlet.2020.12.021. Epub 2020 Dec 23. Cancer Lett. 2021. PMID: 33347908
-
In vitro and in vivo Effects of Lactate on Metabolism and Cytokine Production of Human Primary PBMCs and Monocytes.Front Immunol. 2018 Nov 12;9:2564. doi: 10.3389/fimmu.2018.02564. eCollection 2018. Front Immunol. 2018. PMID: 30483253 Free PMC article.
-
The Tumor Metabolic Microenvironment: Lessons from Lactate.Cancer Res. 2019 Jul 1;79(13):3155-3162. doi: 10.1158/0008-5472.CAN-18-3726. Epub 2019 Jun 6. Cancer Res. 2019. PMID: 31171526 Free PMC article. Review.
-
The Immune Consequences of Lactate in the Tumor Microenvironment.Adv Exp Med Biol. 2020;1259:113-124. doi: 10.1007/978-3-030-43093-1_7. Adv Exp Med Biol. 2020. PMID: 32578174 Review.
Cited by
-
Correlation Analyses Between Serum Interleukin-7, Interleukin-15 and Lactate Provide Insights Into Their Potential Roles in the Regulation of Inflammation in Elderly Septic Patients.Biomark Insights. 2024 Sep 9;19:11772719241275525. doi: 10.1177/11772719241275525. eCollection 2024. Biomark Insights. 2024. PMID: 39257715 Free PMC article.
-
Understanding lactate in the development of Hepatitis B virus-related hepatocellular carcinoma.Infect Agent Cancer. 2024 Jul 15;19(1):31. doi: 10.1186/s13027-024-00593-4. Infect Agent Cancer. 2024. PMID: 39010155 Free PMC article. Review.
-
Lactate Oxidase Disrupts Lactate-Activated RAS and PI3K Oncogenic Signaling.Cancers (Basel). 2024 Aug 10;16(16):2817. doi: 10.3390/cancers16162817. Cancers (Basel). 2024. PMID: 39199589 Free PMC article.
-
Manipulation of metabolic pathways to promote stem-like and memory T cell phenotypes for immunotherapy.Front Immunol. 2023 Jan 18;13:1061411. doi: 10.3389/fimmu.2022.1061411. eCollection 2022. Front Immunol. 2023. PMID: 36741362 Free PMC article. Review.
-
Metabolism heterogeneity in melanoma fuels deactivation of immunotherapy: Predict before protect.Front Oncol. 2022 Dec 22;12:1046102. doi: 10.3389/fonc.2022.1046102. eCollection 2022. Front Oncol. 2022. PMID: 36620597 Free PMC article. Review.
References
-
- Abebayehu D., Spence A. J., Qayum A. A., Taruselli M. T., McLeod J. J. A., Caslin H. L., et al. . (2016). Lactic acid suppresses IL-33–mediated mast cell inflammatory responses via hypoxia-inducible factor-1α–dependent miR-155 suppression. J. Immunol. 197, 2909–2917. doi: 10.4049/jimmunol.1600651, PMID: - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
